Instil Bio (TIL) Research & Development (2020 - 2026)

Instil Bio has reported Research & Development for 7 years, with the latest figure at $270000.0 in Q2 2026.

• On a quarterly basis, Research & Development fell 96.0% year-over-year to $270000.0 in Q2 2026; TTM through Jun 2026 was $13.6 million, a 1.54% decrease from a year earlier, with the FY2025 full-year figure at $24.7 million, up 108.97% from the prior year.
• Research & Development was $270000.0 for Q2 2026 at Instil Bio, down from $669000.0 in the prior quarter.
• The five-year high for Research & Development was $41.5 million in Q2 2022, with the low at $270000.0 in Q2 2026.
• Average Research & Development over 5 years is $12.1 million, with a median of $7.0 million recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Research & Development jumped 1524.02% in 2025, then slumped 96.0% in 2026.
• Over 5 years, Research & Development stood at $20.7 million in 2022, then slumped by 90.43% to $2.0 million in 2023, then tumbled by 44.58% to $1.1 million in 2024, then jumped by 218.2% to $3.5 million in 2025, then slumped by 92.28% to $270000.0 in 2026.
• The last three Research & Development figures came in at $270000.0 (Q2 2026), $669000.0 (Q1 2026), and $3.5 million (Q4 2025), per Business Quant data.